» Authors » Daniel Brook

Daniel Brook

Explore the profile of Daniel Brook including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 65
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Franz B, Dhanani L, Bogart S, Fenstemaker C, Miller W, Hall O, et al.
J Subst Use Addict Treat . 2025 Jan; 171:209633. PMID: 39864554
Introduction: Buprenorphine and other medications for opioid use disorder (MOUD) are highly effective but substantially under prescribed in the rural United States. Among the most cited barriers to buprenorphine prescribing...
2.
Estadt A, Kline D, Miller W, Feinberg J, Hurt C, Mixson L, et al.
Harm Reduct J . 2024 Nov; 21(1):214. PMID: 39614319
Background: People who use drugs (PWUD) in rural communities increasingly use stimulants, such as methamphetamine and cocaine, with opioids. We examined differences in hepatitis C virus (HCV) testing and treatment...
3.
Piscalko H, Dhanani L, Brook D, Hall O, Miller W, Go V, et al.
Ann Med . 2024 Sep; 56(1):2399316. PMID: 39234650
Background: Medications for opioid use disorder (MOUD) are the gold standard. However, significant barriers limit their use in the primary care setting, including limited knowledge of the medications and stigmatizing...
4.
Rudolph A, Nance R, Bobashev G, Brook D, Akhtar W, Cook R, et al.
BMC Med Res Methodol . 2024 Apr; 24(1):94. PMID: 38654219
Background: Accurate prevalence estimates of drug use and its harms are important to characterize burden and develop interventions to reduce negative health outcomes and disparities. Lack of a sampling frame...
5.
Daste F, Walrant A, Holst M, Gadsby J, Mason J, Lee J, et al.
J Cell Biol . 2017 Sep; 216(11):3745-3765. PMID: 28923975
The conditional use of actin during clathrin-mediated endocytosis in mammalian cells suggests that the cell controls whether and how actin is used. Using a combination of biochemical reconstitution and mammalian...
6.
Davies E, Fulton E, Brook D, Hughes D
Br J Clin Pharmacol . 2017 Jan; 83(7):1595-1601. PMID: 28109021
Aims: The success of the Regulation on Orphan Medicinal Products in the European Union is evidenced by the 127 orphan drugs that have had market authorization since 2000. However, the...